Ophthalmic formulations containing substituted gamma lactams and methods for use thereof
US8952051B2 · kind B2 · utility
0Cited by
4References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 4, 2010 |
| Grant date | Feb 10, 2015 |
| Priority date | — |
| Expiry date | Sep 29, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides ophthalmic formulations containing well-defined substituted gamma lactams. The formulations described herein are useful in treating a variety of ocular diseases related to ocular hypertension, such as for example, glaucoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.